Nygren, Peter <br/><br/>
Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  2005 
 - 203-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0284-186X 
<br/><br/><label>Standard No.: </label>10.1080/02841860510029798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--therapeutic use<br/>Bevacizumab<br/>Cetuximab<br/>Chemotherapy, Adjuvant<br/>Colonic Neoplasms--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Neoplasm Metastasis<br/>Rectal Neoplasms--drug therapy<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors